Stryker Revenue

Macroaxis Equity Filters allow users to customize the simple screener criteria below or select from a set of available quick indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations

Revenue Analysis

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of business and is important item when evaluating financial statements of a company. Revenues from a firm's main business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which given company operates.
Stryker 
Revenue 
 = 
Money Received 
Discounts and Returns 
 = 
10.47 B

Distress Driver Correlations

 Stryker Revenues 
Benchmark  Embed   Timeline 

About Revenue

Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Compare to competition

Stryker Revenue Assessment

 Revenue 
Benchmark  Embed   Stryker Comparables 
Based on latest financial disclosure Stryker Corporation reported 10.47 B of revenue. This is 74.38% higher than that of the Healthcare sector, and 658.71% higher than that of Medical Appliances and Equipment industry, The Revenue for all stocks is 3.09% lower than the firm.
ETFsFundsStocks

Filter other Stocks by Revenue

Category
Revenue Input Range 
Industry  
Click to run this filter
Filter Other Equities
  
Showing first 16 of many similar equities found by Revenue
MDT NYQMedtronic plc
28.72 B
ABT NYQAbbott Laboratories
20.56 B
SYK NYQStryker Corporation
10.47 B
BSX NYQBoston Scientific Corporation
7.88 B
ISRG NMSIntuitive Surgical Inc
2.52 B
ZBH NYQZimmer Biomet Holdings Inc
7.53 B
EW NYQEdwards Lifesciences Corp
2.74 B
STJ NYQSt Jude Medical Inc
5.8 B
SNN NYQSmith Nephew plc
4.69 B
HOLX NMSHologic Inc
2.78 B
DGX NYQQuest Diagnostics Inc
7.5 B
RMD NYQResMed Inc
1.84 B
VAR NYQVarian Medical Systems Inc
3.12 B
DHRM NCMDehaier Medical Systems Limited
1.32 M
OFIX NMSOrthofix International NV
408.53 M
XRAY NMSDENTSPLY International Inc
3.11 B
You can backtest this sub-set of assets as a synthetic portfolio or check its risk adjusted returns  
Peer Comparison
Stryker Revenue Comparison
  Revenue 
Benchmark  Embed   Stryker Comparables 
Stryker is rated third in revenue category among related companies.
Did you try this?
Run Technical Analysis Now
   

Technical Analysis

Check basic technical indicators and analysis based on most latest market data
Hide  View All  Next  Launch Technical Analysis
Return On Equity18.24 %
Return On Asset8.02 %
Profit Margin15.33 %
Operating Margin22.89 %
Current Valuation48.32 B
Shares Outstanding374.3 M
Shares Owned by Insiders8.29 %
Shares Owned by Institutions76.00 %
Number of Shares Shorted5.2 M
Price to Earning27.76 times
Price to Book4.87 times
Price to Sales4.23 times
Revenue10.47 B
Gross Profit6.6 B
EBITDA2.85 B
Net Income1.6 B
Cash and Equivalents3.66 B
Cash per Share9.77 times
Total Debt7.64 B
Debt to Equity0.84 times
Current Ratio2.17 times
Book Value Per Share24.31 times
Cash Flow from Operations833 M
Short Ratio5.48 times
One Year High123.55
One Year Low86.68
Earnings Per Share4.24 times
Price to Earnings To Growth2.03 times
Number of Employees27 K
Beta0.58
Market Capitalization44.08 B
Total Asset20.52 B
Retained Earnings8.28 B
Working Capital4.22 B
Current Asset7.82 B
Current Liabilities3.6 B
Z Score3.0